At this year’s Radiological Society of North America’s, RSNA, 2025 Annual Meeting, GE HealthCare (GEHC) will showcase a “wave of significant innovations grounded by its legacy and deep, global commitment to advancing precision care,” the company said. This year at RSNA, GE HealthCare will demonstrate new and recently announced innovations, including: Photonova Spectra, Next-gen SIGNA MRI technology, Pristina Recon DL; Pristina Recon DL; Vivid Pioneer; Flyrcado injection; Definium Pace Select.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare receives FDA premarket authorization for Pristina Recon DL
- Strategic Acquisition of Intelerad Boosts GE Healthcare’s SaaS Offerings and Revenue Potential
- GE Healthcare’s Strategic Acquisition of Intelerad: Balancing Long-Term Gains with Short-Term Challenges
- Hold Rating on GE Healthcare Technologies Inc: Strategic Acquisition of Intelerad Brings Long-Term Growth Potential Amid Initial EPS Dilution Concerns
- GE Healthcare’s Intelerad Acquisition: Balancing Long-term Growth with Short-term EPS Dilution